Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1,2-Dilauroyl-sn-glycero-3-phosphocholine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
1,2-Dilauroyl-sn-glycero-3-phosphocholine (DLPC) is a synthetic phosphatidylcholine, a class of phospholipids that are fundamental components of biological membranes. It features a choline head group and two lauroyl (dodecanoyl) fatty acid chains attached to a glycerol backbone. DLPC is widely utilized in biochemical and biophysical research, particularly in the study of lipid bilayers, membrane structure, and drug delivery systems. It has also been identified as an agonist for the Liver Receptor Homolog-1 (LRH-1) and plays a role in membrane-mediated cell signaling and enzyme activation, such as that of phosphatidylcholine transfer protein (PCTP). While phosphatidylcholines in general are found in dietary supplements and have been investigated for various therapeutic applications, DLPC itself is primarily a research chemical or a component in specialized formulations.
- Other names
- Diundecyl Phosphatidyl Choline1,2-Didodecanoyl-sn-glycero-3-phosphocholineDLPCDilauroyl phosphatidylcholine
02
Targets
NR5A2 (Purinergic receptor P2X5)
Beyond the preview
Go deeper on 1,2-Dilauroyl-sn-glycero-3-phosphocholine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1,2-Dilauroyl-sn-glycero-3-phosphocholine.